AndroGel Cost in Maine 2026: Cash Price, Insurance, and Cheaper Alternatives

What Is the Cash Price of AndroGel in Maine in 2026?

Brand-name AndroGel costs approximately $510 per month at Maine retail pharmacies when paid out of pocket in 2026. That figure applies to the most common strength, 1.62% gel (40.5 mg per actuation pump), dispensed as a 75-gram metered-dose pump lasting 30 days. The older 1% formulation carries a similar list price. Neither formulation is cheap without coverage, but several pathways can reduce that number to near zero or to roughly $120 per month.

AbbVie, the manufacturer of AndroGel, holds a list price that has remained close to $510 for the standard monthly supply across most U.S. states, including Maine. Retail pricing data from 2026 pharmacy benefit managers and GoodRx-tracked pharmacy networks confirm this range for Portland, Bangor, Lewiston, and Augusta locations. The actual amount a patient pays depends entirely on whether they carry commercial insurance with a formulary benefit, qualify for Maine Medicaid (MaineCare), use the AbbVie savings card, or switch to a compounded or generic alternative.

Generic testosterone gel 1.62% is available through select Maine pharmacies and can run $80 to $180 per month depending on the dispensing pharmacy and whether a discount card is applied. Patients should ask their pharmacist specifically for the generic, because the brand is often dispensed by default.

The T-Trials consortium, a set of seven placebo-controlled studies in 788 men 65 and older with low testosterone, found that transdermal testosterone treatment produced statistically significant improvements in sexual function and bone mineral density compared with placebo (1). That evidence base underpins why clinicians and insurance reviewers consider testosterone gel medically necessary for diagnosed hypogonadism.

Does Maine Medicaid (MaineCare) Cover AndroGel?

MaineCare covers AndroGel for male hypogonadism, but prior authorization is required before the claim will be paid. Without an approved PA, the pharmacy will bill the patient the full cash price.

To obtain a PA under MaineCare, the prescribing clinician must document a confirmed diagnosis of hypogonadism (ICD-10 E29.1 for primary, E23.0 for secondary), provide at least two morning serum total testosterone values below 300 ng/dL drawn on separate days, and show that the patient has symptoms consistent with testosterone deficiency. The Endocrine Society's 2018 clinical practice guideline states: "We recommend making a diagnosis of androgen deficiency only in men with consistent symptoms and signs and unequivocally low serum testosterone levels" (2). MaineCare reviewers apply essentially the same standard.

Once the PA is approved, MaineCare's preferred drug list typically places testosterone gel on a preferred tier, meaning the patient copay is low, often $3 to $10 per month for eligible enrollees. Generic testosterone gel is more likely to appear on the preferred tier than brand AndroGel, so the PA should specify the drug class rather than the brand if the goal is lowest patient cost.

PA approvals are generally valid for 12 months. Renewal requires re-documentation of ongoing hypogonadism symptoms and typically a repeat testosterone level. Clinicians in Maine have noted that PA denials most often occur when the two required testosterone labs were drawn at different times of day rather than in the morning, when the diurnal peak produces the highest and most diagnostically reliable values.

Which Private Insurance Plans in Maine Cover AndroGel?

Most commercial plans sold in Maine, including those through Anthem Blue Cross Blue Shield of Maine, Harvard Pilgrim Health Care (now Point32Health), and employer-sponsored plans regulated under ERISA, cover testosterone gel when medically necessary. Coverage details vary by plan year and formulary tier.

Anthem's individual and small-group Maine formularies for 2026 generally place brand AndroGel on Tier 3 (non-preferred brand) while generic testosterone gel sits on Tier 2 (preferred generic). A Tier 3 copay for a 30-day supply can range from $45 to $95 after the deductible is met. Before the deductible, patients may pay the full negotiated rate, which is typically $200 to $350 per month under commercial contracts, less than the $510 list price.

Patients covered by Maine employer plans (self-insured ERISA plans) should check their Summary of Benefits and Coverage document for the testosterone gel tier. These plans are not bound by Maine state insurance mandates, so formulary decisions vary widely. Calling the plan's pharmacy benefit manager before filling the first prescription avoids surprise bills.

The FDA-approved prescribing information for AndroGel 1.62% confirms the indication as replacement therapy in adult males with primary or secondary hypogonadism (3). Presenting this label language in a PA submission can strengthen the medical necessity argument with commercial insurers.

How Does the AbbVie Savings Card Work for Maine Patients?

The AbbVie myAbbVie Assist savings card reduces the out-of-pocket cost to as low as $0 per month for commercially insured patients who meet eligibility criteria. It does not work for patients covered by Medicare, Medicaid, or any other government-funded program, including MaineCare.

Enrollment is done online at AbbVie's patient assistance portal or through the prescribing clinician's office. Once enrolled, the card is presented at the pharmacy like a secondary insurance card. The savings apply automatically to each fill as long as the patient remains commercially insured and continues to meet income and insurance eligibility thresholds.

For Maine patients who are uninsured and below certain income levels, AbbVie's myAbbVie Assist patient assistance program (separate from the savings card) may provide AndroGel at no cost. The program requires proof of income, proof of Maine residency, and a prescription from a licensed Maine clinician. Processing typically takes two to four weeks, so patients should plan to use a bridge supply or short-term cash-pay option while the application is reviewed.

Is Compounded Testosterone Gel Legal in Maine?

Compounded testosterone gel is legal in Maine when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. This is the most cost-effective option for many men who do not have insurance coverage or who have been denied a PA.

A 503A compounding pharmacy is a traditional compounding pharmacy that operates under state board of pharmacy oversight and fills prescriptions for individual patients. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounded preparations are exempt from FDA approval requirements as long as the compounding is done pursuant to a valid prescription and does not copy a commercially available product in a way that creates an undue regulatory concern (4). Maine has several licensed 503A pharmacies that compound testosterone gel.

Compounded testosterone gel typically costs $100 to $140 per month in Maine, with $120 being the most commonly quoted price from telepharmacy-linked compounding pharmacies serving the state. The active ingredient is testosterone USP, the same molecule found in brand AndroGel. Compounded gels can be prepared at strengths not commercially available (for example, 2% or 5%) and in different base vehicles, which may improve absorption or skin tolerability for some patients.

The HealthRX clinical team uses the following framework to guide patients toward the right testosterone gel option based on coverage status and clinical need:

HealthRX Testosterone Gel Cost Pathway for Maine Patients (2026)

1. Covered by MaineCare: Submit PA with two morning testosterone labs (<300 ng/dL) and symptom documentation. Expected patient cost after approval: $3 to $10/month for generic gel.
2. Covered by commercial insurance: Check formulary tier. Apply AbbVie savings card if brand is prescribed and copay exceeds $30/month. Expected cost: $0 to $95/month depending on tier and deductible status.
3. Uninsured, income-eligible: Apply for myAbbVie Assist patient assistance program. Bridge with compounded testosterone gel at $120/month while awaiting approval.
4. Uninsured, not income-eligible or prefer faster access: Use licensed Maine 503A compounding pharmacy with telehealth prescription. Cost: $100 to $140/month.
5. Medicare Part D: Brand AndroGel may fall in a high tier. Request generic testosterone gel first; apply for Extra Help (LIS) if income-qualified. Generic may cost $10 to $47/month under standard Part D.

Telehealth Prescribing of AndroGel in Maine

AndroGel can be prescribed via telehealth in Maine. Testosterone is a Schedule III controlled substance under the Controlled Substances Act, so the prescribing clinician must hold a valid DEA registration and, under the current rules that extended pandemic-era telemedicine flexibilities, may prescribe testosterone without an in-person visit as long as the platform meets audio-visual requirements and the prescriber is licensed in Maine (5).

As of early 2026, DEA rules still permit the initial prescription of Schedule III substances via audio-visual telemedicine for established patients. Patients new to testosterone therapy should confirm that their telehealth provider follows current DEA guidance, since proposed rule changes could require at least one in-person visit before new Schedule III prescriptions are issued. Monitoring the DEA's rulemaking page and consulting a Maine-licensed clinician remains the safest approach.

From a practical standpoint, the telehealth visit for testosterone evaluation in Maine typically costs $75 to $150 for the initial consultation, plus the cost of lab work. Required labs before prescribing include total testosterone (two morning draws), complete blood count (hematocrit threshold applies), PSA for men over 40, and a lipid panel. Ongoing monitoring visits are often $50 to $75 every three to six months, depending on the platform.

The Endocrine Society guideline recommends monitoring hematocrit at three to six months after initiation and then annually, with a target hematocrit below 54% (2). Telehealth clinicians practicing in Maine are expected to follow this standard regardless of the prescribing modality.

Generic Testosterone Gel Versus Brand AndroGel in Maine

Generic testosterone gel 1.62% is therapeutically equivalent to brand AndroGel 1.62% under FDA's AB-rating standard, meaning the two products have demonstrated bioequivalence in pharmacokinetic studies. For most patients, substituting the generic at the pharmacy produces the same serum testosterone levels and clinical outcomes.

The FDA's Orange Book lists multiple generic testosterone gel 1.62% products as AB-rated to AndroGel 1.62% (3). Maine pharmacists can legally perform a generic substitution unless the prescriber writes "dispense as written" on the prescription. Patients who want the generic should ask the prescriber to write the prescription generically (testosterone gel 1.62%) rather than specifying the brand.

Cash prices for generic testosterone gel 1.62% at Maine pharmacies in 2026 range from approximately $80 to $180 per month depending on the pharmacy chain and the application of third-party discount programs. Using a GoodRx or similar discount card at independent Maine pharmacies, rather than large chains, sometimes produces prices in the $80 to $100 range for a 30-day supply.

The T-Trials data (1) used a 1% testosterone gel formulation delivered through a transdermal system comparable to AndroGel 1%. The 1.62% formulation delivers a higher dose per actuation, which is why most prescribers now default to the 1.62% strength for dose titration flexibility. Both strengths are available as generics.

Side Effects and Monitoring That Affect Total Treatment Cost in Maine

Testosterone gel therapy carries a monitoring burden that adds to the effective monthly cost. Patients receiving testosterone in Maine should budget for lab work and follow-up visits in addition to the drug itself.

The FDA label for AndroGel warns of polycythemia, which is an increase in red blood cell mass that raises cardiovascular risk (3). A complete blood count costs approximately $15 to $40 at Maine draw sites with discount lab pricing and $40 to $80 billed through insurance before deductible. PSA testing for men over 40 adds another $20 to $50 per draw. Total annual monitoring lab cost for a compliant patient runs $200 to $400 out of pocket if not covered by insurance.

Secondary exposure is a specific risk with testosterone gel that affects families with children or pregnant partners. The FDA issued a black-box warning in 2009 regarding virilization in children who had secondary exposure through skin contact with treated adults (3). Clinicians prescribing AndroGel or generic testosterone gel in Maine must counsel patients to apply the gel to covered skin areas, allow full drying, and wash hands after application.

Men with a PSA above 4 ng/mL or a history of prostate cancer are generally not candidates for testosterone therapy under Endocrine Society guidance. The guideline states: "We suggest that clinicians should not prescribe testosterone therapy to men with... untreated prostate cancer" (2). This screening step is part of the pre-treatment workup that telehealth and in-person prescribers in Maine are expected to complete.

A total monthly cost model for a Maine patient using compounded testosterone gel with standard monitoring looks like this: $120 for compounded gel plus roughly $33 for pro-rated lab costs (assuming $400 per year) plus $12 for pro-rated telehealth follow-up visits (assuming two visits at $75 each per year). That puts the realistic all-in monthly cost at approximately $165. Compare that to $510 cash price for brand AndroGel without assistance, and the savings potential is clear.

How Maine Compares to National AndroGel Pricing

The $510 monthly cash price for brand AndroGel in Maine matches the national average list price almost exactly. AbbVie has maintained a relatively uniform national list price for AndroGel, with minor variations by pharmacy contract. States without Medicaid expansion or with fewer 503A compounding pharmacies tend to have higher effective patient costs because fewer low-cost pathways exist.

Maine expanded Medicaid under the ACA in 2018, which created the MaineCare pathway for uninsured and low-income men with hypogonadism. Before expansion, men in Maine earning 100% to 138% of the federal poverty level fell into a coverage gap. That gap no longer exists, meaning a previously uninsured Maine man diagnosed with hypogonadism in 2026 can access MaineCare coverage and pay $3 to $10 per month for testosterone gel rather than $510 cash.

The prevalence of male hypogonadism in the United States is estimated at 2.1% to 12.8% of adult men depending on the diagnostic threshold applied, based on data from the European Male Aging Study and U.S. population surveys (6). Maine's adult male population of approximately 530,000 suggests that tens of thousands of Maine men may have clinically low testosterone, a portion of whom are either untreated or paying more than necessary.

Steps to Pay the Lowest Price for Testosterone Gel in Maine Right Now

Getting to the lowest price requires four concrete steps.

First, confirm the diagnosis with two morning total testosterone labs. Values must be below 300 ng/dL on both draws to meet most PA criteria. LabCorp and Quest both have draw sites in Maine; with a discount lab card, each draw costs $25 to $45.

Second, determine your coverage category. If you have MaineCare, direct your prescriber to submit a PA immediately with both lab values attached. If you have commercial insurance, ask the pharmacy to run the AbbVie savings card as secondary. If you have no insurance, ask your prescriber to write for a compounded 1.62% or 2% testosterone gel and send the prescription to a Maine-licensed 503A compounding pharmacy.

Third, verify the compounding pharmacy's Maine Board of Pharmacy license before submitting your prescription. The Maine Board of Pharmacy maintains a public license lookup tool at its website. A licensed 503A pharmacy must be operating under a valid Maine permit.

Fourth, schedule monitoring labs at three months and at 12 months. Hematocrit above 54% requires dose reduction or temporary discontinuation per the Endocrine Society guideline (2). Catching polycythemia early avoids the cost and risk of complications.

At the time of writing in early 2026, the lowest documented all-in monthly cost for a Maine patient receiving testosterone gel therapy is approximately $133: a $120 compounded gel plus $8 in pro-rated lab costs through discount lab pricing plus a $5 telehealth maintenance visit share. Patients with active MaineCare coverage and an approved PA can achieve $3 to $10 per month for the gel itself.